Trovò, Luca https://orcid.org/0000-0002-5864-3776
Kouvaros, Stylianos https://orcid.org/0000-0003-0735-9908
Schwenk, Jochen
Fernandez-Fernandez, Diego https://orcid.org/0000-0003-1431-3705
Fritzius, Thorsten https://orcid.org/0000-0002-3597-6623
Rem, Pascal Dominic https://orcid.org/0009-0003-7732-2825
Früh, Simon https://orcid.org/0000-0001-6804-5385
Gassmann, Martin https://orcid.org/0000-0001-6201-3032
Fakler, Bernd https://orcid.org/0000-0001-7264-6423
Bischofberger, Josef
Bettler, Bernhard https://orcid.org/0000-0003-0842-8207
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A-152970)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030-205198)
Deutsche Forschungsgemeinschaft (TRR 152 - project ID 239283807)
Deutsche Forschungsgemeinschaft (FA 332/15-1 - project ID 439189341)
Deutsche Forschungsgemeinschaft (CIBSS - EXC-2189 - project ID 390939984)
Article History
Received: 18 August 2023
Revised: 11 April 2024
Accepted: 12 April 2024
First Online: 2 May 2024
Disclosure and competing interests statement
: BB is a member of the scientific advisory board of Addex Therapeutics, Geneva, a pharmaceutical company focused on the development of allosteric modulators for neurological disorders. All other authors declare no competing interests.